Pearly Shuyi Ng

7PUBLICATIONS
58CO-AUTHORS
Medical bacteriologyTraditional Chinese medicine and treatmentsProteins and peptidesCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 13, 2026
A Series of Pyrazolo-Quinazoline Amines Inhibits the Cytochrome bd Oxidase in Mycobacterium tuberculosis.

Samsher Singh, Pearly Shuyi Ng, Umayal Lakshmanan

|Jan 07, 2026
Discovery of IID432 for Chagas Disease: A Cyanotriazole Inhibitor of Trypanosoma cruzi Topoisomerase II Achieves Sterile Cure After Short-Term Treatment in a Chronic Infection Model.

Olivier René, Manuel Saldivia, Maxime Dauphinais

|Dec 23, 2025
Correction to "Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 Mpro Inhibitor with Pan-Coronavirus Activity".

Qian Wen Tan, Subramanyam Vankadara, Jia Yi Fong

|Aug 07, 2025
Discovery of an Orally Bioavailable Reversible Covalent SARS-CoV-2 Mpro Inhibitor with Pan-Coronavirus Activity.

Qian Wen Tan, Subramanyam Vankadara, Jia Yi Fong

|Oct 30, 2024
Button-Push On-Demand Synthesis for Rapid Optimization of Antiviral Peptidomimetics.

Duanshuai Tian, Ting Wei Tan, Ronald Toh Kuan Hai

|Jun 29, 2023
Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections.

Srinivasa P S Rao, Matthew K Gould, Jonas Noeske

Pageof 2

Frequent Collaborators

3 joint publications

Weijun Xu

2 joint publications

Srinivasa P S Rao

2 joint publications

C S Brian Chia

2 joint publications

Chuhui Huang